Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEHR TEST SYSTEMS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEHR TEST SYSTEMS's regulatory disclosures and financial reporting.
AEHR TEST SYSTEMS CFO Chris Siu reported equity compensation activity and related tax withholding transactions. He acquired 6,165 and 6,079 shares of common stock as stock awards at no cost, including shares issued upon vesting of performance-based restricted stock units. To satisfy tax withholding obligations on these vestings, 2,213 shares at $84.425 per share and 1,139 shares at $69.96 per share were withheld, which the footnotes state do not represent sales by him. After these transactions, he directly holds 78,812 shares of common stock, and an additional 5,706 shares are held indirectly by a trust.
Aehr Test Systems VP Alistair N. Sporck reported routine equity compensation activity involving restricted stock units. He acquired a total of 8,534 shares of common stock as stock awards, including shares issued upon vesting of a performance-based RSU.
To cover tax withholding obligations on the vesting, the company withheld 2,472 shares at prices of $84.425 and $69.96 per share, which the filing states does not represent a sale by Sporck. After these transactions, he directly holds 26,223 shares, with an additional 5,177 shares held indirectly by a trust.
AEHR Test Systems executive Alberto Salamone reported routine equity compensation activity. He received grants of 1,978 and 4,048 shares of common stock at $0.00 per share as restricted stock unit awards, including performance-based RSUs. The awards vest in equal one-sixteenth installments every three full calendar months, as long as he remains employed. To cover related tax obligations upon vesting, 1,453 shares at $84.425 and 556 shares at $69.96 were withheld by the company, which the disclosure states does not represent market sales. Following these transactions, Salamone directly holds 51,838 shares, and this amount includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS CTO Donald P. Richmond II reported routine stock-based compensation activity. On July 1, he received awards totaling 6,165 and 2,369 shares of common stock at no cost in connection with restricted stock units, including performance-based RSUs. A total of 2,524 shares were withheld on July 1 and July 2 at prices of $84.425 and $69.96 per share to cover tax obligations upon vesting, which the company notes do not represent sales. After these transactions, he directly holds 187,420 shares, and this amount includes shares subject to unvested restricted stock units that will vest over time if employment conditions are met.
Aehr Test Systems executive Vernon Rogers reported compensation-related stock activity rather than open-market trading. On July 1, 2026, he acquired 6,165 and 2,393 shares of common stock at $0.00 per share as shares were issued upon vesting of performance-based restricted stock units, according to the footnotes.
To satisfy tax withholding obligations from these vestings, 2,213 shares were withheld on July 1, 2026 at $84.425 per share and 337 shares were withheld on July 2, 2026 at $69.96 per share. The filing notes these tax withholdings do not represent sales by Rogers. After these transactions, he directly holds 153,585 shares of common stock, which include shares subject to unvested restricted stock units.
AEHR Test Systems President and CEO Gayn Erickson reported compensation-related stock activity. On July 1, he received 35,886 and 11,899 shares of common stock at $0.00 per share from RSU awards, including performance-based RSUs. On July 1 and July 2, a total of 26,016 shares were withheld at $84.425 and $69.96 per share to cover tax obligations, which the filing states are not sales. After these transactions, he holds 206,429 shares directly and 197,723 shares indirectly through a trust.
AEHR Test Systems Chief Operating Officer Adil Engineer reported equity compensation changes tied to restricted stock units. On July 1, he acquired 3,079 and 6,165 shares of common stock at $0.00 per share as grants or awards upon vesting of performance-based and other RSUs.
To cover tax obligations on these vestings, 2,213 shares on July 1 at $84.425 and 437 shares on July 2 at $69.96 were withheld, which the filing states do not represent sales. After these transactions, he directly holds 47,506 shares, and this amount includes shares subject to unvested RSUs.
DANESH FARIBA reported acquisition or exercise transactions in this Form 4 filing.
AEHR Test Systems director Fariba Danesh received a grant of 1,658 shares of Common Stock through restricted stock unit awards at no cash cost. One-fourth of the units will vest at the end of each three full calendar months, as long as she continues serving on the Board. Following this award, she is reported as holding 14,801 shares of Common Stock, and this amount includes shares subject to unvested restricted stock units.
SCOTT GEOFFREY GATES reported acquisition or exercise transactions in this Form 4 filing.
Aehr Test Systems director Geoffrey Scott reported updated holdings and a new equity award. He received 1,658 shares of common stock as a grant or award at $0.0000 per share, increasing his direct ownership to 54,522 shares. The filing also reflects indirect holdings of 50,000 shares held by his spouse and 40,686 shares held by a trust.
According to the footnotes, these shares are subject to restricted stock unit terms. One-fourth of the RSU shares vest after each three full calendar months from the grant date, as long as he continues to serve on the Board. The reported amounts include unvested RSUs, meaning some shares are scheduled to vest over time rather than being fully available immediately.
AEHR TEST SYSTEMS director Laura Oliphant received an equity award of 1,658 shares of common stock as a grant or award. The shares were acquired at a stated price of $0.00 per share and are structured as restricted stock units.
After this award, Oliphant directly holds 18,317 shares of common stock, which includes shares subject to unvested restricted stock units. One-fourth of the total restricted stock unit award vests at the end of each three full calendar months following the grant date, as long as she continues to serve on the company’s Board of Directors.